Merus drug, with immunotherapy, shows preliminary survival boost for patients with head and neck cancer Dutch biotech has begun a randomized study to prove its drug’s superiority to current treatments

https://www.statnews.com/2025/05/22/merus-drug-with-keytruda-shows-preliminary-survival-boost-head-and-neck-cancer/